Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07449195 · ClinicalTrials.gov registry record · NA
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
A NA study of Ocular Tumor, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 7
- Study locations
NCT07449195 is a NA study of Ocular Tumor that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 60 participants. The trial reports 7 study locations across 2 states.
The verdict
NCT07449195, a NA study of Ocular Tumor, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Intalight Dream OCT
- DIAGNOSTIC_TEST Heidelberg Spectralis OCT
Study Locations (7)
New York
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) - Commack
- Memorial Sloan Kettering Westchester (Consent Only) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites) - New York
- Memorial Sloan Kettering Cancer Center @ Nassau (Consent only) - Uniondale
New Jersey
- Memorial Sloan Kettering at Basking Ridge (Consent Only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only) - Middletown
- Memorial Sloan Kettering Bergen (Consent Only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-27 |
| Est. Completion | 2028-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07449195
The ClinicalTrials.gov registry entry for NCT07449195 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ocular Tumor appearing as the primary indexed condition, and to 2 interventions - of which Intalight Dream OCT is the first listed.
NCT07449195 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT07449195 about?
NCT07449195 is a clinical study titled "A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors". The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
What is the current status of trial NCT07449195?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-27. Estimated completion is 2028-02-27.
What conditions does trial NCT07449195 study?
This clinical trial studies the following conditions: Ocular Tumor.
What interventions are being tested in trial NCT07449195?
The interventions under investigation include: Intalight Dream OCT (DIAGNOSTIC_TEST), Heidelberg Spectralis OCT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07449195?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07449195 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ocular Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.